Drug & intervention
aluminum hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML [Gaviscon]
RxCUI 576423
What this record represents
SBDC · RxNormThis is an RxNorm SBDC drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
GavisconBN · CureCurrent ID 20947
Gaviscon ChewableBN · CureCurrent ID 55745
aluminum hydroxide 160 MG / magnesium carbonate 105 MG [Gaviscon]SBDC · CureCurrent ID 35104
aluminum hydroxide / magnesium carbonate Chewable Tablet [Gaviscon]SBDF · CureCurrent ID 30747
aluminum hydroxide / magnesium carbonate Oral Suspension [Gaviscon]SBDF · CureCurrent ID 30299
aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML [Gaviscon]SBDC · CureCurrent ID 52307
aluminum hydroxide 160 MG / magnesium carbonate 105 MG Chewable Tablet [Gaviscon]SBD · CureCurrent ID 23970
aluminum hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML Oral Suspension [Gaviscon]SBD · CureCurrent ID 33181
aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Gaviscon]SBD · CureCurrent ID 52308
Advertisement
Active ingredients and chemical structures
RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.